Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | MMP1 | P03956 | 1/20 | 0.31 |
| ▸ | MMP2 | P08253 | 1/20 | 0.31 |
| ▸ | MMP3 | P08254 | 1/20 | 0.31 |
| ▸ | MMP9 | P14780 | 1/20 | 0.31 |
| ▸ | MMP13 | P45452 | 1/20 | 0.31 |
| ▸ | KLK7 | P49862 | 1/20 | 0.31 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29743149 | 1.00 | TP53 (0.50) | TP53CYP1A2GAACYP2C9PKM | |
| SCHEMBL18651139 | 1.00 | TP53 (0.50) | TP53CYP1A2GAACYP2C9PKM | |
| SCHEMBL28010837 | 1.00 | TP53 (0.50) | TP53CYP1A2GAACYP2C9PKM | |
| SCHEMBL29743150 | 1.00 | TP53 (0.50) | TP53CYP1A2GAACYP2C9PKM | |
| SCHEMBL12046593 | 1.00 | TP53 (0.50) | TP53CYP1A2GAACYP2C9PKM | |
| SCHEMBL23673200 | 1.00 | TP53 (0.50) | TP53CYP1A2GAACYP2C9PKM | |
| SCHEMBL44463 | 1.00 | TP53 (0.50) | TP53CYP1A2GAACYP2C9PKM | |
| SCHEMBL8557040 | 1.00 | TP53 (0.50) | TP53CYP1A2GAACYP2C9PKM | |
| SCHEMBL21295799 | 0.97 | TP53 (0.48) | TP53CYP1A2GAACYP2C9PKM | |
| Ammonia Solution, Strong SCHEMBL3684743 | 0.97 | TP53 (0.48) | TP53CYP1A2GAACYP2C9PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4705373-A1 | PROCESS AND SYSTEM FOR REMOVING LACTIDE FROM A LACTIDE-CONTAINING GAS STREAM | Purac Biochem B.V. (NL) | 2026-03-11 | — | — | EP | disclosed |
| US-20260055076-A1 | PROCESS AND SYSTEM FOR REMOVING LACTIDE FROM A LACTIDE-CONTAINING GAS STREAM | TOTALENERGIES CORBION B.V. (NL) | 2026-02-26 | — | — | US | disclosed |
| EP-4648749-A1 | MULTI-COMPONENT INTRAVAGINAL RING | THE POPULATION COUNCIL, INC. (US) | 2025-11-19 | — | — | EP | disclosed |
| US-20250296913-A1 | GENERATION OF PEROXYHYDROXYCARBOXYLIC ACID AND THE USE THEREOF | ECOLAB USA INC. | 2025-09-25 | — | — | US | disclosed |
| US-20250261681-A1 | METHOD FOR HYDROLYSIS OF LACTIC ACID FOR AEROSOL DELIVERY DEVICE | RAI STRATEGIC HOLDINGS INC (US) | 2025-08-21 | — | — | US | disclosed |
| US-12371403-B2 | Generation of peroxyhydroxycarboxylic acid and the use thereof | ECOLAB USA INC. (US) | 2025-07-29 | — | — | US | disclosed |
| US-12310396-B2 | Method for hydrolysis of lactic acid for aerosol delivery device | RAI STRATEGIC HOLDINGS, INC. (US) | 2025-05-27 | — | — | US | disclosed |
| WO-2024231226-A1 | PROCESS AND SYSTEM FOR REMOVING LACTIDE FROM A LACTIDE-CONTAINING GAS STREAM | PURAC BIOCHEM B.V. (NL) | 2024-11-14 | — | — | WO | disclosed |
| WO-2024152034-A1 | MULTI-COMPONENT INTRAVAGINAL RING | THE POPULATION COUNCIL, INC. (US) | 2024-07-18 | — | — | WO | disclosed |
| EP-3277099-B9 | HIGH EFFICIENCY OXALATE-DEGRADING ENZYMES FOR DEGRADATION OF INSOLUBLE AND SOLUBLE OXALATE | OXIDIEN PHARMACEUTICALS LLC (US) | 2024-05-29 | — | — | EP | disclosed |
| US-11820737-B2 | Generation of peroxyhydroxycarboxylic acid and the use thereof | ECOLAB USA INC. (US) | 2023-11-21 | — | — | US | disclosed |
| EP-3277099-B1 | HIGH EFFICIENCY OXALATE-DEGRADING ENZYMES FOR DEGRADATION OF INSOLUBLE AND SOLUBLE OXALATE | OXIDIEN PHARMACEUTICALS LLC (US) | 2023-11-08 | — | — | EP | disclosed |
| US-11603524-B2 | High efficiency oxalate-degrading enzymes for degradation of insoluble and soluble oxalate | OXIDIEN PHARMACEUTICALS, LLC (US) | 2023-03-14 | — | — | US | disclosed |
| EP-4097082-A1 | GENERATION OF PEROXYHYDROXYCARBOXYLIC ACID AND THE USE THEREOF | Ecolab USA Inc. (US) | 2022-12-07 | — | — | EP | disclosed |
| US-20220298497-A1 | HIGH EFFICIENCY OXALATE-DEGRADING ENZYMES FOR DEGRADATION OF INSOLUBLE AND SOLUBLE OXALATE | ORENZYMES LLC | 2022-09-22 | — | — | US | disclosed |
| EP-3256460-B1 | METHOD FOR MANUFACTURING LACTIDE | PURAC BIOCHEM BV (NL) | 2022-08-03 | — | — | EP | disclosed |
| EP-3154928-B1 | METHOD FOR THE PREPARATION OF (S)-2-ACETYLOXYPROPIONIC ACID AND DERIVATIVES THEREOF | BRACCO IMAGING SPA (IT) | 2020-03-04 | — | — | EP | disclosed |
| CN-110256226-A | A method of D-ALPHA-Hydroxypropionic acid is prepared by C3, xylose, glucose and one step of corn stover | 四川大学 | 2019-09-20 | — | — | CN | disclosed |
| CN-109401993-A | A kind of D-ALPHA-Hydroxypropionic acid production bacterial strain and the method using bacterial strain production D-ALPHA-Hydroxypropionic acid | 吉林中粮生化有限公司 | 2019-03-01 | — | — | CN | disclosed |
| CN-106884001-A | A kind of method for recombinating Alkaliphilic bacillus and its preparation method and application and preparing D-ALPHA-Hydroxypropionic acid | 中国科学院微生物研究所 | 2017-06-23 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250296913-A1 | GENERATION OF PEROXYHYDROXYCARBOXYLIC ACID AND THE USE THEREOF | PRDX2, PRDX1, PRDX4 | TP53 3486/4885CYP1A2 1077/4885GAA 3110/4885 |
| US-20260055076-A1 | PROCESS AND SYSTEM FOR REMOVING LACTIDE FROM A LACTIDE-CONTAINING GAS STREAM | LCT, LDHA, SI | TP53 2748/4885CYP1A2 3150/4885GAA 484/4885 |
| US-11820737-B2 | Generation of peroxyhydroxycarboxylic acid and the use thereof | PRDX2, PRDX1, PRDX4 | TP53 3486/4885CYP1A2 1077/4885GAA 3110/4885 |
| US-12371403-B2 | Generation of peroxyhydroxycarboxylic acid and the use thereof | PRDX2, PRDX1, PRDX4 | TP53 3486/4885CYP1A2 1077/4885GAA 3110/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.